Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 21, Issue 10, Pages 677-694
Publisher
Future Medicine Ltd
Online
2020-06-16
DOI
10.2217/pgs-2020-0005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ADME pharmacogenetics: future outlook for Russia
- (2019) Karin B Mirzaev et al. PHARMACOGENOMICS
- Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants
- (2018) Miriam Saiz-Rodríguez et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan
- (2017) Karin B. Mirzaev et al. Genetic Testing and Molecular Biomarkers
- CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure
- (2017) Jasmine A. Luzum et al. PHARMACEUTICAL RESEARCH
- Addressing phenoconversion: the Achilles' heel of personalized medicine
- (2015) Rashmi R. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic testing to guide therapy? Not for ticagrelor!
- (2015) C. Hengstenberg et al. EUROPEAN HEART JOURNAL
- Effect of genetic variations on ticagrelor plasma levels and clinical outcomes
- (2015) Christoph Varenhorst et al. EUROPEAN HEART JOURNAL
- CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis
- (2015) Xuan Niu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- CYP2D6, CYP3A5, and CYP3A4 gene polymorphisms in Russian, Tatar, and Bashkir populations
- (2015) O. E. Mustafina et al. RUSSIAN JOURNAL OF GENETICS
- The Genetic Legacy of the Expansion of Turkic-Speaking Nomads across Eurasia
- (2015) Bayazit Yunusbayev et al. PLoS Genetics
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: A systematic review and meta-analysis
- (2013) Jie Yang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: Genetic testing to support switching to new oral anticoagulants
- (2012) Agnieszka I. Mazur-Bialy et al. THROMBOSIS RESEARCH
- Metabolism of Ophthalmic Timolol: New Aspects of an Old Drug
- (2011) Marjo Volotinen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Emergency Hospitalizations for Adverse Drug Events in Older Americans
- (2011) Daniel S. Budnitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microarray-Based Detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 Allele Frequencies in Native Russians
- (2010) Olga Gra et al. Genetic Testing and Molecular Biomarkers
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics
- (2010) Laurent Becquemont et al. PHARMACOGENOMICS
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Characterization of pharmacogenetically relevantCYP2D6andABCB1gene polymorphisms in a Portuguese population sample
- (2009) C. Correia et al. CELL BIOCHEMISTRY AND FUNCTION
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
- (2009) Shu-Feng Zhou CLINICAL PHARMACOKINETICS
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement
- (2008) D. Wang et al. BLOOD
- Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users
- (2008) MJ Bijl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes
- (2008) Oksana Makeeva et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now